What is the current Pharmaceutical Grade Crospovidonum (PVPP) market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the PVPP market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Pharmaceutical Grade Crospovidonum (PVPP) market?

Increasing demand for pharmaceutical applications drives the market.

What challenges does the PVPP market face?

Stringent regulatory requirements pose challenges for market growth.

Which regions are the leaders in the Pharmaceutical Grade Crospovidonum (PVPP) market?

North America and Europe are the leading regions.

Who are the top companies in the PVPP market?

BASF and Evonik are among the top companies.

What future opportunities exist in the Pharmaceutical Grade Crospovidonum (PVPP) market?

Growing demand in emerging economies presents opportunities.

How does technology impact the PVPP market future outlook?

Advancements in technology improve production efficiency.

What is the current regulatory landscape for the PVPP market?

Regulatory bodies enforce strict quality standards.

Pharmaceutical Grade Crospovidonum (PVPP) - Strategic Insights: Analysis 2025 and Forecasts 2033

Pharmaceutical Grade Crospovidonum (PVPP) by Application (Tablets, Capsules, Others), by Types (Type A, Type B), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $432 million

CAGR: 7.9%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $432 million

CAGR: 7.9%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Pharmaceutical Grade Crospovidonum (PVPP) Market Overview

The Pharmaceutical Grade Crospovidonum (PVPP) market refers to the industry involved in the production and distribution of high-purity Crospovidone, a type of polyvinylpolypyrrolidone (PVPP) used as an excipient in pharmaceutical applications. As the global pharmaceutical industry continues to expand, the Pharmaceutical Grade Crospovidonum (PVPP) market size is expected to grow significantly, driven by increasing demand for high-quality excipients. The growth outlook for the Pharmaceutical Grade Crospovidone (PVPP) market is promising, with a forecasted market size of approximately $1.4 billion by 2026 and a compound annual growth rate (CAGR) of around 7-8% during the forecast period from 2026 to 2033. The industry expansion is driven by factors such as the increasing use of Crospovidone in oral solid dosage forms, the growing demand for high-purity excipients, and the rising adoption of contract manufacturing in the pharmaceutical industry.

Loading chart…

The Pharmaceutical Grade Crospovidonum (PVPP) market is influenced by several key forces, including technological advancements in excipient manufacturing, regulatory requirements for high-purity excipients, and changing consumer behavior towards more effective and safe pharmaceutical products. The largest region for the Pharmaceutical Grade Crospovidonum (PVPP) market is currently North America, while the fastest-growing region is Asia Pacific, driven by the increasing demand for pharmaceutical products in countries such as China and India. The industry is expected to continue growing, driven by the increasing demand for high-quality excipients and the expanding pharmaceutical industry.

Report Overview

Report Attribute	Details
Market size value in 2025	432.00 million
Revenue forecast in 2033	753.43 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ashland; BASF; ISP Pharmaceuticals; JRS Pharma; Jiangxi Alpha Hi-tech Pharmaceutical; Anhui Sunhere Pharmaceutical Excipients; Guangdong Yumay Chemical; Jiaozuo Zhongwei Special Products Pharmaceutical; Yuking Technology; Boai NKY Pharmaceuticals; Huangshan Bonsun Pharmaceuticals; Sichuan Tianhua
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pharmaceutical Grade Crospovidonum (PVPP) market is poised for significant growth, driven by increasing demand for high-quality pharmaceutical excipients. The growth forecast for the market is expected to be substantial, with the Pharmaceutical Grade Crospovidonum (PVPP) market size anticipated to expand rapidly over the next few years.

Growth Drivers2 items

Increasing demand for pharmaceutical excipients with high purity and quality is driving the growth of the Pharmaceutical Grade Crospovidonum (PVPP) market

Advances in technology and manufacturing processes are enabling the production of high-quality Pharmaceutical Grade Crospovidonum (PVPP), further fueling market growth

Restraints2 items

Stringent regulatory requirements and quality standards are limiting the entry of new players in the Pharmaceutical Grade Crospovidonum (PVPP) market

Fluctuations in raw material prices and supply chain disruptions are affecting the profitability of Pharmaceutical Grade Crospovidonum (PVPP) manufacturers

Opportunities2 items

Growing demand for Pharmaceutical Grade Crospovidonum (PVPP) in emerging economies is creating new opportunities for market players

Increasing focus on research and development is leading to the discovery of new applications for Pharmaceutical Grade Crospovidonum (PVPP), further expanding the market

Challenges2 items

Intense competition among Pharmaceutical Grade Crospovidonum (PVPP) manufacturers is putting pressure on prices and profit margins

Ensuring compliance with changing regulatory requirements and maintaining high-quality standards is a significant challenge for Pharmaceutical Grade Crospovidonum (PVPP) market players

Market Segmentation

Loading chart…

The Application segment of the Pharmaceutical Grade Crospovidonum (PVPP) market refers to the various uses of PVPP in pharmaceutical formulations. This segment is crucial in understanding the Pharmaceutical Grade Crospovidonum (PVPP) segmentation as it directly impacts the market size. The applications of PVPP include tablet binding, capsule filling, and as an excipient in various drug formulations, contributing significantly to the overall market size.

The Types segment of the Pharmaceutical Grade Crospovidonum (PVPP) market is categorized into subtypes, including [object Object] and [object Object]. Each subtype has its unique characteristics, functionalities, and market demand, contributing to the overall market taxonomy. Understanding these subtypes is essential for analyzing the market trends, competition, and growth prospects, ultimately providing insights into the Pharmaceutical Grade Crospovidonum (PVPP) market size.

Pharmaceutical Grade Crospovidonum (PVPP) Segmentation Breakdown7 items

Application

Tablets

Capsules

Others

Types

Type A

Type B

Regional Insights

Loading chart…

The Pharmaceutical Grade Crospovidonum (PVPP) market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, driven by key drivers such as increasing adoption of PVPP in pharmaceutical applications, favorable policies supporting the growth of the pharmaceutical industry, and significant investments in research and development. The region's large population, growing demographics, and improving infrastructure also contribute to its dominance in the market.

North America is the fastest-growing region, with a growth rate driven by factors such as increasing demand for high-quality pharmaceuticals, rising awareness about the benefits of PVPP, and growing ecosystem maturity in the region. Europe is also expected to experience significant growth, driven by regulatory support, increasing research activities, and a well-established pharmaceutical industry. Latin America and Middle East & Africa are expected to experience moderate growth, driven by increasing adoption of PVPP in pharmaceutical applications and growing demand for high-quality pharmaceuticals.

Key Drivers by Region5 items

Asia Pacific: increasing adoption, favorable policies, significant investments

North America: increasing demand, rising awareness, growing ecosystem maturity

Europe: regulatory support, increasing research, well-established pharmaceutical industry

Latin America: increasing adoption, growing demand

Middle East & Africa: increasing adoption, growing demand

Competitive Landscape

The Pharmaceutical Grade Crospovidonum (PVPP) market is moderately consolidated, with a mix of global players and local companies competing on pricing, distribution, product innovation, certifications, and regulatory approvals. The Pharmaceutical Grade Crospovidonum (PVPP) competitive landscape is driven by key competitive levers such as product quality, supply chain reliability, and customer relationships. Global players focus on innovation and regulatory compliance, while local companies emphasize cost competitiveness and regional market knowledge.

Companies in the Pharmaceutical Grade Crospovidonum (PVPP) market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have adopted distinct strategic focuses:

Ashland: regional expansion

BASF: vertical integration

ISP Pharmaceuticals: premium pricing

JRS Pharma: OEM tie-ups

Jiangxi Alpha Hi-tech Pharmaceutical: innovation pipeline

Anhui Sunhere Pharmaceutical Excipients: local manufacturing

Key Pharmaceutical Grade Crospovidonum (PVPP) Companies12 items

Ashland

BASF

ISP Pharmaceuticals

JRS Pharma

Jiangxi Alpha Hi-tech Pharmaceutical

Anhui Sunhere Pharmaceutical Excipients

Guangdong Yumay Chemical

Jiaozuo Zhongwei Special Products Pharmaceutical

Yuking Technology

Boai NKY Pharmaceuticals

Huangshan Bonsun Pharmaceuticals

Sichuan Tianhua

Market Ecosystem

The Pharmaceutical Grade Crospovidonum (PVPP) ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the interaction of these participants, from raw material supply to end-user adoption. The ecosystem boundaries are defined by the flow of materials, services, and information, influencing how value is generated and distributed among participants.

Raw material suppliers — provide PVPP base materials

OEMs/manufacturers — produce PVPP products

Technology providers — offer specialized PVPP processing technologies

System integrators/EPCs — design and implement PVPP systems

Distributors/channel partners — deliver PVPP products to end users

Regulators/standards bodies — establish PVPP quality and safety standards

End users/buyers — purchase and utilize PVPP products

In the Pharmaceutical Grade Crospovidonum (PVPP) ecosystem, control points are primarily held by regulators and standards bodies, influencing adoption through stringent quality and safety standards. Dependency risks arise from input constraints, such as raw material availability, and approvals from regulatory authorities. Switching costs and partnerships are critical, as end users often require customized PVPP products, leading to high loyalty and partnership requirements. Furthermore, the ecosystem differs by region, with varying regulatory requirements and market demands, highlighting the need for a comprehensive value chain analysis to navigate these complexities.

Recent Industry Insights

The Pharmaceutical Grade Crospovidonum (PVPP) industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing production capacities and expanding distribution networks. Notably, mergers and acquisitions have also been on the rise, with major companies acquiring smaller peers to consolidate their market positions and diversify their product portfolios.

Furthermore, there have been several product launches and technology upgrades aimed at improving the quality and efficacy of Pharmaceutical Grade Crospovidonum (PVPP). Regulatory changes, particularly in the European and North American regions, have emphasized the need for stricter quality control measures, driving the adoption of advanced manufacturing technologies. Additionally, a shift in consumer preferences towards high-quality pharmaceutical products has fueled the demand for premium PVPP products, prompting manufacturers to invest in research and development and funding rounds to support their expansion plans.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Pharmaceutical Grade Crospovidonum (PVPP) market outlook. The market exhibits moderate attractiveness, driven by increasing demand for high-quality excipients in pharmaceutical formulations. The competitive intensity is relatively high, with key players focusing on product differentiation and strategic partnerships. Looking ahead, the long-term outlook for the Pharmaceutical Grade Crospovidonum (PVPP) market is promising, with opportunities for growth in emerging markets and innovation in product development.

The innovation landscape is characterized by ongoing research and development efforts to improve product quality and functionality. However, the demand-supply balance poses a key risk factor, as fluctuations in raw material availability and pricing can impact market stability. Overall, the Pharmaceutical Grade Crospovidonum (PVPP) market outlook is positive, with opportunities for growth and innovation, but also requires careful management of risk factors to ensure long-term success.

11 items

1. Executive Summary

2. Pharmaceutical Grade Crospovidonum (PVPP) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pharmaceutical Grade Crospovidonum (PVPP) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Pharmaceutical Grade Crospovidonum (PVPP) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Tablets

6.1.2. Capsules

6.1.3. Others

6.2. Global Pharmaceutical Grade Crospovidonum (PVPP) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Type A

6.2.2. Type B

6.3. Global Pharmaceutical Grade Crospovidonum (PVPP) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Pharmaceutical Grade Crospovidonum (PVPP) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pharmaceutical Grade Crospovidonum (PVPP) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pharmaceutical Grade Crospovidonum (PVPP) Market Competition by Key Manufacturers

8.1. Global Pharmaceutical Grade Crospovidonum (PVPP) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Pharmaceutical Grade Crospovidonum (PVPP): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Ashland

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BASF

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. ISP Pharmaceuticals

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. JRS Pharma

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Jiangxi Alpha Hi-tech Pharmaceutical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Anhui Sunhere Pharmaceutical Excipients

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Guangdong Yumay Chemical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Jiaozuo Zhongwei Special Products Pharmaceutical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Yuking Technology

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Boai NKY Pharmaceuticals

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Huangshan Bonsun Pharmaceuticals

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Sichuan Tianhua

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pharmaceutical Grade Crospovidonum (PVPP) Market

Figure 4: Global Pharmaceutical Grade Crospovidonum (PVPP) Market: Drivers

Figure 5: Global Pharmaceutical Grade Crospovidonum (PVPP) Market: Challenges

Figure 6: Global Pharmaceutical Grade Crospovidonum (PVPP) Market: Trends

Figure 7: Global Pharmaceutical Grade Crospovidonum (PVPP) Market: Opportunity

Figure 8: Global Pharmaceutical Grade Crospovidonum (PVPP) Market: Restraint

Figure 9: Global Pharmaceutical Grade Crospovidonum (PVPP) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Pharmaceutical Grade Crospovidonum (PVPP) Market Value (USD Million) By Region

Figure 15: Global Pharmaceutical Grade Crospovidonum (PVPP) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Pharmaceutical Grade Crospovidonum (PVPP) Market Value (USD Million) By Region

Figure 23: Global Pharmaceutical Grade Crospovidonum (PVPP) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Pharmaceutical Grade Crospovidonum (PVPP) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pharmaceutical Grade Crospovidonum (PVPP) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pharmaceutical Grade Crospovidonum (PVPP) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Pharmaceutical Grade Crospovidonum (PVPP) Market Value (USD Million) By Region

Table 10: Global Pharmaceutical Grade Crospovidonum (PVPP) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Pharmaceutical Grade Crospovidonum (PVPP) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Pharmaceutical Grade Crospovidonum (PVPP) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Pharmaceutical Grade Crospovidonum (PVPP) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Ashland Basic Information And Sales Area

Table 31: Ashland. Products Portfolio

Table 32: BASF Basic Information And Sales Area

Table 33: BASF. Products Portfolio

Table 34: ISP Pharmaceuticals Basic Information And Sales Area

Table 35: ISP Pharmaceuticals. Products Portfolio

Table 36: JRS Pharma Basic Information And Sales Area

Table 37: JRS Pharma. Products Portfolio

Table 38: Jiangxi Alpha Hi-tech Pharmaceutical Basic Information And Sales Area

Table 39: Jiangxi Alpha Hi-tech Pharmaceutical. Products Portfolio

Table 40: Anhui Sunhere Pharmaceutical Excipients Basic Information And Sales Area

Table 41: Anhui Sunhere Pharmaceutical Excipients. Products Portfolio

Table 42: Guangdong Yumay Chemical Basic Information And Sales Area

Table 43: Guangdong Yumay Chemical. Products Portfolio

Table 44: Jiaozuo Zhongwei Special Products Pharmaceutical Basic Information And Sales Area

Table 45: Jiaozuo Zhongwei Special Products Pharmaceutical. Products Portfolio

Table 46: Yuking Technology Basic Information And Sales Area

Table 47: Yuking Technology. Products Portfolio

Table 48: Boai NKY Pharmaceuticals Basic Information And Sales Area

Table 49: Boai NKY Pharmaceuticals. Products Portfolio

Table 50: Huangshan Bonsun Pharmaceuticals Basic Information And Sales Area

Table 51: Huangshan Bonsun Pharmaceuticals. Products Portfolio

Table 52: Sichuan Tianhua Basic Information And Sales Area

Table 53: Sichuan Tianhua. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Pharmaceutical Grade Crospovidonum (PVPP) Market Value (USD Million) By Region

Table 59: Global Pharmaceutical Grade Crospovidonum (PVPP) Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Pharmaceutical Grade Crospovidonum (PVPP) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	432.00 million
Revenue forecast in 2033	753.43 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Ashland; BASF; ISP Pharmaceuticals; JRS Pharma; Jiangxi Alpha Hi-tech Pharmaceutical; Anhui Sunhere Pharmaceutical Excipients; Guangdong Yumay Chemical; Jiaozuo Zhongwei Special Products Pharmaceutical; Yuking Technology; Boai NKY Pharmaceuticals; Huangshan Bonsun Pharmaceuticals; Sichuan Tianhua
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing demand for pharmaceutical excipients with high purity and quality is driving the growth of the Pharmaceutical Grade Crospovidonum (PVPP) market

Advances in technology and manufacturing processes are enabling the production of high-quality Pharmaceutical Grade Crospovidonum (PVPP), further fueling market growth

Restraints2 items

Stringent regulatory requirements and quality standards are limiting the entry of new players in the Pharmaceutical Grade Crospovidonum (PVPP) market

Fluctuations in raw material prices and supply chain disruptions are affecting the profitability of Pharmaceutical Grade Crospovidonum (PVPP) manufacturers

Opportunities2 items

Growing demand for Pharmaceutical Grade Crospovidonum (PVPP) in emerging economies is creating new opportunities for market players

Increasing focus on research and development is leading to the discovery of new applications for Pharmaceutical Grade Crospovidonum (PVPP), further expanding the market

Challenges2 items

Intense competition among Pharmaceutical Grade Crospovidonum (PVPP) manufacturers is putting pressure on prices and profit margins

Ensuring compliance with changing regulatory requirements and maintaining high-quality standards is a significant challenge for Pharmaceutical Grade Crospovidonum (PVPP) market players

Market Segmentation

Loading chart…

Pharmaceutical Grade Crospovidonum (PVPP) Segmentation Breakdown7 items

Application

Tablets

Capsules

Others

Types

Type A

Type B

Regional Insights

Loading chart…

Key Drivers by Region5 items

Asia Pacific: increasing adoption, favorable policies, significant investments

North America: increasing demand, rising awareness, growing ecosystem maturity

Europe: regulatory support, increasing research, well-established pharmaceutical industry

Latin America: increasing adoption, growing demand

Middle East & Africa: increasing adoption, growing demand

Competitive Landscape

Ashland: regional expansion

BASF: vertical integration

ISP Pharmaceuticals: premium pricing

JRS Pharma: OEM tie-ups

Jiangxi Alpha Hi-tech Pharmaceutical: innovation pipeline

Anhui Sunhere Pharmaceutical Excipients: local manufacturing

Key Pharmaceutical Grade Crospovidonum (PVPP) Companies12 items

Ashland

BASF

ISP Pharmaceuticals

JRS Pharma

Jiangxi Alpha Hi-tech Pharmaceutical

Anhui Sunhere Pharmaceutical Excipients

Guangdong Yumay Chemical

Jiaozuo Zhongwei Special Products Pharmaceutical

Yuking Technology

Boai NKY Pharmaceuticals

Huangshan Bonsun Pharmaceuticals

Sichuan Tianhua

Market Ecosystem

Raw material suppliers — provide PVPP base materials

OEMs/manufacturers — produce PVPP products

Technology providers — offer specialized PVPP processing technologies

System integrators/EPCs — design and implement PVPP systems

Distributors/channel partners — deliver PVPP products to end users

Regulators/standards bodies — establish PVPP quality and safety standards

End users/buyers — purchase and utilize PVPP products

Recent Industry Insights

Analyst Overview

Table of Contents